| Literature DB >> 24961641 |
Masood Ahmad Rizvi1, Santosh Guru2, Tahira Naqvi3, Manjeet Kumar4, Navanath Kumbhar5, Showkat Akhoon3, Shazia Banday3, Shashank K Singh2, Shashi Bhushan2, G Mustafa Peerzada3, Bhahwal Ali Shah6.
Abstract
A target synthesis of a library of symmetric aromatic diselenides was attempted with the aim of generating anticancer lead compounds. Out of thirteen screened molecules (1-13) against a panel of human cancer cell lines, compound 8 exhibited highest cell growth inhibition in Human leukemia HL-60 cells with IC50 value of 8 μM. Compound 8 had a good pro-apoptotic potential as evidenced from several apoptotic protocols like DNA cell cycle analysis and monitoring of apoptotic bodies formation using phase contrast and nuclear microscopy with Hoechst 33,258. Also, 8 significantly inhibits S phase of the cell cycle and eventually trigger apoptosis in HL-60 cells through mitochondrial dependent pathway substantiated by the loss of mitochondrial potential. A theoretical investigation of DNA binding ability of 8 showed that it selectively bind to minor groove of DNA, where it is stabilized by hydrogen bonding and hydrophobic interactions.Entities:
Keywords: Anti-cancer; Apoptosis; DNA-binding; Diselenides; In silico
Mesh:
Substances:
Year: 2014 PMID: 24961641 DOI: 10.1016/j.bmcl.2014.05.075
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823